Company Overview and News
MEXICO, 17 juill. 2018 (GLOBE NEWSWIRE) -- Avis aux médias - TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) a annoncé aujourd’hui la mise en service de son projet de gazoduc Topolobampo dans le nord du Mexique, avec une capacité d’acheminement de 670 millions de pieds cubes de gaz naturel par jour aux marchés des États de Chihuahua et de Sinaloa. Le projet représente un investissement d’environ 1,2 milliard de dollars américains et sera raccordé en amont au gazoduc Mazatlan de l’entreprise.
MEXICO CITY, July 16, 2018 (GLOBE NEWSWIRE) -- Media Advisory – TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) today announced its Topolobampo Pipeline project has been placed into service in northern Mexico, providing capacity for 670 million cubic feet of natural gas per day to markets in the states of Chihuahua and Sinaloa. The project represents an investment of approximately US$1.2 billion and provides the upstream interconnection with the company’s Mazatlan Pipeline.
CALGARY, Alberta, 12 juill. 2018 (GLOBE NEWSWIRE) -- Communiqué de presse – TransCanada Corporation (TSX:TRP), (NYSE:TRP) (TransCanada) enregistrera une téléconférence et une webémission le jeudi 2 août 2018 pour discuter de son bilan financier du deuxième trimestre 2018.
The company will benefit from higher oil prices due to its exposure via the CO2 segment.
WFCNP APA KMI.WS WFC.PRL WFC.PRJ ENB WFC.PRT WFC.PRR WFC.PRQ KMI.PRA WFC.PRP KMI WFC.PRO WFC.PRN TRP WFC.PRY WFC.PRX KMR CVB WFC.PRW WFC.PRV WFC WFC.WS TRP ENB KMRFZ
CALGARY, Alberta, July 11, 2018 (GLOBE NEWSWIRE) -- News Release – TransCanada Corporation (TSX:TRP), (NYSE:TRP) (TransCanada) will hold a teleconference and webcast on Thursday, August 2, 2018 to discuss its second quarter 2018 financial results.
Kinder Morgan, Inc. (KMI - Free Report) recently announced its intention to restart the construction work for expansion of the Trans Mountain pipeline in August. The project was paused in spring owing to resistance from various provincial governments of British Columbia as well as municipalities, native groups, and environmental activists.
ENBBF TRP KMI.WS ENB ENB KMI.PRA KMI TRP EBBNF KMR CVB KMRFZ CEO
Jacobs Engineering Group Inc. (JEC - Free Report) has been selected for AusNet Services' Regulated Energy Services panel for engineering and design work associated with regulated transmission and distribution assets. This three-year contract incorporates both greenfield and brownfield asset upgrades, infrastructure replacements, and the delivery of new energy infrastructure in an evolving and innovative sector.
TRP SAUNF BLT XOM BHPBF AZI SU JEC BHP TRP BBL BHP BHPLF AST SU
CALGARY, Alberta, June 28, 2018 (GLOBE NEWSWIRE) -- News Release – TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada or Company) today announced that it has replenished the capacity available under its existing $1.0 billion, or its U.S. dollar equivalent at-the-market equity program (ATM Program). This will allow the Company to issue additional common shares from treasury (Common Shares) having an aggregate gross sales price of up to $1.
TRP TRP DTK BR
Midstream and MLPs traded well this week, but not as well as you'd expect given a 5%+ oil move and strength in income securities (like utilities). The OPEC meeting Friday turned out to be a catalyst despite no surprise, because of how well-managed expectations were. Oil, energy stocks and MLPs were sharply higher Friday, and the Dow finished positive for the first time in 9 days.
ARLP ETP.PRC OMP CQP KMI.WS ENB NSH KMI.PRA KMI CAPL KMR CVB TRP LNG SRLP ETP SHLX NRP ENBL NS CQH PBA BKEP ETE PAGP WGP TEP TEGP CEQP TRP AMGP OKE PAA KEYUF ENLK OCIP NS.PRC NS.PRB SRE.PRA TCP DM SRE KMLGF CVRR SEMG TRGP KMRFZ NS.PRA
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to TSX:TRP / Transcanada Corp. on message board site Silicon Investor.
|ITRP - Intrepid Technology u0026 Resources, Inc.||TRPH TriPath Technology Inc.|
|transcanada pipelines (TRP)||Tripath Technology, Inc. (Nasdaq:TRPH)|
|Tripos (TRPS): Will Surge!|